ArticleFrontiers in oral health2025
Does chlorhexidine improve periodontal health and bacterial profiles in patients with special health care needs? A systematic review and meta-analysis.
Article in Frontiers in oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The purpose of this systematic review was to evaluate the effectiveness of chlorhexidine (CHX)-containing products as adjuncts to mechanical oral hygiene practices in maintaining gingival health in patients with intellectual disability. Materials and methods: An electronic search was conducted in three databases-PubMed, Embase, and Web of Science-1945- December 31, 2024. Two calibrated independent reviewers assessed the selected studies based on the inclusion and exclusion criteria. The main outcomes measured were changes in the gingival index, plaque index, and complications. A meta-analysis was performed to analyze the efficiency of adjunct CHX products compared with controls (mechanical plaque removal only). Additionally, meta-regression was conducted to investigate the factors contributing to these outcomes. Results: Twelve randomized controlled trials involving individuals with special health care needs (SHCN) were included across varied clinical settings. CHX use was associated with a statistically significant reduction in plaque accumulation (Hedges' g = -1.491; 95% CI: -2.067 to -0.914; Conclusion: In patients with SHCN short-term use (4-6 weeks), especially with 0.2% formulations, appeared to offer the greatest benefit while maintaining acceptable tolerability. While adverse effects such as tooth staining and taste alterations are common, they are generally mild and self-limiting. These findings support the short-term use of CHX as an adjunctive measure in oral hygiene management for individuals with SHCN, with use tailored to the patient's needs and monitored closely by a dental provider to minimize complications. Systematic Review Registration: (CRD420251003198).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.